We wish to inform you that the Board of Directors of Asarfi Hospital Limited ('the Company'), at its meeting held today i.e. 09 February, 2026, has considered and approved the Unaudited ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board of Asarfi Hospital met on 9 February 2026 and approved its unaudited standalone and consolidated financial results for the quarter and nine months ended 31 December 2025, along with the limited review report from statutory auditor R. K. Thakkar & Co. The company explicitly declared that the auditor issued an unmodified (clean) opinion on both sets of results. From the clearly readable cash flow statement, standalone net profit after tax for nine months FY26 was about ₹1,298 lakh versus ₹1,098 lakh for the full FY25, and net cash from operations swung positive at around ₹1,086 lakh (vs negative ₹384 lakh in FY25), pushing closing cash balance to ₹993 lakh from ₹132 lakh at March 2025. Consolidated numbers showed a similar improvement, with 9M PAT of ₹1,274 lakh and operating cash inflow of ₹1,085 lakh. The P&L line items in the filing appear largely illegible, so revenue, EBITDA and margin specifics cannot be reliably read from this document.
Clean auditor opinion and a sharp swing to positive operating cash flow with a much higher cash pile suggest improving operational health for the small-cap hospital operator, though limited P&L visibility means shareholders should look at the full results PDF for revenue and margin trends before drawing conclusions.